Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Abstract Background Cardiovascular (CV) safety of one anti-diabetic medication over another remains partially delineated. We sought to assess the comparative effect on CV outcomes among novel anti-diabetic agents. Methods This study was registered with the International Prospective Register of Syste...
Main Authors: | Xiao-dong Zhuang, Xin He, Da-ya Yang, Yue Guo, Jian-gui He, Hai-peng Xiao, Xin-xue Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-018-0722-z |
Similar Items
SodaBot: A Software Agent Environment and Construction System
by: Coen, Michael H.
Published: (2004)
by: Coen, Michael H.
Published: (2004)
Similar Items
-
Dr. Schneck replies (American Journal of Psychiatry (2009) 166, (370-371))
by: Schneck, C, et al.
Published: (2009) -
Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials
by: Da-ya Yang, et al.
Published: (2019-04-01) -
Impact of virtual agent facial emotions and attention on N170 ERP amplitude: comparative study
by: Luisa Kirasirova, et al.
Published: (2025-02-01) -
Erratum to “Bilateral Botryoid Wilms Tumor presented with acute renal failure” [Radiology Case Reports 16 (2021) 166–170]
by: Gholamreza Bahoush, MD, et al.
Published: (2022-09-01) -
Introducción 166
by: Camilo Borrero
Published: (1991-12-01)